£81.58

Springer Hodgkin's and Non-Hodgkin's Lymphoma: 131 (Cancer Treatment and Research, 131)

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£82 today · previous high £82 · all-time low £81

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days • 91 data points

Historical
Generating forecast...
£81.58 £81.43 £81.46 £81.49 £81.53 £81.56 £81.59 08 March 2026 30 March 2026 22 April 2026 14 May 2026 06 June 2026

Price Distribution

Price distribution over 91 days • 1 price levels

Days at Price
91 days 0 23 46 68 91 £82 Days at Price

Price Analysis

Most common price: £82 (91 days, 100.0%)

Price range: £82 - £82

Price levels: 1 different prices over 91 days

Description

Over recent years, there has been a dramatic increase in knowledge of the biology of the lymphomas which has been accompanied by the emergence of new treatments that offer both improvements in efficacy and reduction in toxicity. Molecular profiling of tumor tissue and other new advances have led to a better understanding of the genetic basis of lymphoma, identification of new therapeutic targets, and potentially valuable prognostic information. Monoclonal antibody therapies, radioimmunoconjugates and other new agents such as proteosome inhibitors are providing important new treatment options for patients. In this volume, an internationally recognized group of experts provides a comprehensive overview of the biology, pathology, standard treatments, and novel approaches in management of patients across the complex landscape of lymphoma subtypes. Researchers and practitioners alike will welcome this useful summary of the state of the art in this field.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
21 September 2014
Listed Since
01 October 2010

Barcode

No barcode data available

Similar Products You Might Like

Lymphoma: Pathology, Diagnosis and Treatment
86% match

Lymphoma: Pathology, Diagnosis and Treatment

Cambridge University Press

£67.16 20 May 2026
Hematopathology in Oncology: 121 (Cancer Treatment and Research, 121)
86% match

Hematopathology in Oncology: 121 (Cancer Treatment and Research, 121)

Springer

£73.85 25 May 2026
Malignant Lymphomas: Biology and Treatment: An Update (ESO Monographs)
85% match

Malignant Lymphomas: Biology and Treatment: An Update (ESO Monographs)

Springer

£77.39 04 Jun 2026
Pediatric Lymphomas (Pediatric Oncology)
85% match

Pediatric Lymphomas (Pediatric Oncology)

Springer

£95.70 05 Jun 2026
Malignant Lymphomas and their Management: 16 (Recent Results in Cancer Research, 16)
84% match

Malignant Lymphomas and their Management: 16 (Recent Results in Cancer Research, 16)

Springer

£72.56 26 May 2026
Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide
84% match

Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide

Springer

£98.27 06 Jun 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
83% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 05 Jun 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
83% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£77.37 01 Jun 2026
Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)
83% match

Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)

Humana

£107.98 26 May 2026
Lymphoma: 115 (Methods in Molecular Medicine, 115)
83% match

Lymphoma: 115 (Methods in Molecular Medicine, 115)

Humana

£107.98 26 May 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
83% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£113.94 01 Jun 2026
Adult T-cell Leukemia/Lymphoma
82% match

Adult T-cell Leukemia/Lymphoma

Springer

£99.03 06 Jun 2026
Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)
82% match

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)

Springer

£113.76 11 May 2026
Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research
82% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research

Springer

£107.98 31 May 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
82% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£164.68 03 Jun 2026
Malignant Brain Tumors: State-of-the-Art Treatment
82% match

Malignant Brain Tumors: State-of-the-Art Treatment

Springer

£88.73 06 Jun 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
82% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 25 May 2026
Pathobiology of Human Germ Cell Neoplasia: 123 (Recent Results in Cancer Research, 123)
82% match

Pathobiology of Human Germ Cell Neoplasia: 123 (Recent Results in Cancer Research, 123)

Springer

£113.93 06 Jun 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
82% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£163.85 31 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
82% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 26 May 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
82% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 29 May 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
81% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.64 25 May 2026
Molecular Targeted Therapy of Lung Cancer
81% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.70 06 Jun 2026
Histopathologie der Non-Hodgkin-Lymphome: (nach der Kiel-Klassifikation)
81% match

Histopathologie der Non-Hodgkin-Lymphome: (nach der Kiel-Klassifikation)

Springer

£76.38 01 Jun 2026